Humana Inc. (NYSE:HUM – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2024 earnings per share estimates for shares of Humana in a report released on Thursday, September 14th. Cantor Fitzgerald analyst S. James now anticipates that the insurance provider will earn $32.00 per share for the year, down from their prior forecast of $32.19. Cantor Fitzgerald has a “Overweight” rating and a $597.00 price target on the stock. The consensus estimate for Humana’s current full-year earnings is $28.25 per share.
A number of other equities analysts have also recently issued reports on the company. Sanford C. Bernstein increased their target price on Humana from $568.00 to $599.00 and gave the stock a “market perform” rating in a report on Tuesday, August 8th. JPMorgan Chase & Co. downgraded Humana from an “overweight” rating to a “neutral” rating and lowered their price target for the stock from $576.00 to $540.00 in a research report on Friday, July 7th. Royal Bank of Canada reduced their price objective on Humana from $637.00 to $594.00 and set an “outperform” rating for the company in a report on Thursday, August 3rd. Mizuho lowered their price target on shares of Humana from $615.00 to $550.00 in a report on Tuesday, July 11th. Finally, Truist Financial upped their price target on shares of Humana from $530.00 to $550.00 and gave the company a “hold” rating in a research report on Thursday, August 3rd. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $594.53.
Humana Stock Performance
Shares of HUM stock opened at $470.77 on Monday. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.37 and a quick ratio of 1.37. Humana has a fifty-two week low of $423.29 and a fifty-two week high of $571.30. The stock’s 50-day moving average is $468.27 and its two-hundred day moving average is $486.74. The firm has a market cap of $58.33 billion, a P/E ratio of 17.57, a PEG ratio of 1.22 and a beta of 0.66.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 EPS for the quarter, beating the consensus estimate of $8.88 by $0.06. Humana had a return on equity of 20.70% and a net margin of 3.42%. The business had revenue of $26.75 billion during the quarter, compared to the consensus estimate of $25.83 billion. During the same period in the prior year, the business posted $8.67 earnings per share. Humana’s revenue was up 13.0% compared to the same quarter last year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is currently 13.21%.
Institutional Trading of Humana
A number of hedge funds have recently added to or reduced their stakes in the company. MV Capital Management Inc. raised its position in shares of Humana by 40.8% in the first quarter. MV Capital Management Inc. now owns 69 shares of the insurance provider’s stock valued at $33,000 after buying an additional 20 shares during the last quarter. MAI Capital Management raised its holdings in Humana by 2.6% during the first quarter. MAI Capital Management now owns 796 shares of the insurance provider’s stock worth $387,000 after purchasing an additional 20 shares in the last quarter. Humankind Investments LLC increased its holdings in shares of Humana by 4.3% in the 1st quarter. Humankind Investments LLC now owns 513 shares of the insurance provider’s stock valued at $249,000 after acquiring an additional 21 shares during the period. Trust Investment Advisors raised its position in Humana by 5.3% during the 4th quarter. Trust Investment Advisors now owns 441 shares of the insurance provider’s stock worth $226,000 after buying an additional 22 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its stake in shares of Humana by 11.9% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 207 shares of the insurance provider’s stock worth $93,000 after purchasing an additional 22 shares during the period. 91.86% of the stock is owned by hedge funds and other institutional investors.
About Humana
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
- Five stocks we like better than Humana
- Most Volatile Stocks, What Investors Need to Know
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- How to Invest in Virtual Reality
- MarketBeat Week in Review – 9/11 – 9/15
- Are Penny Stocks a Good Fit for Your Portfolio?
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
